3-year-old girl celebrates end of her chemo treatment

Reporter: Marcello Cuadra Writer: Drew Hill
Published: Updated:
Libbi and her parents
Libbi and her parents Credit: Golisano Children’s Hospital

A fighter makes it to her finish line. Three-year-old Libbi is finally finished with chemotherapy after she was diagnosed with cancer two years ago.

Now, she’s getting to celebrate this important milestone with her family. Chris LeDuff is Libbi’s dad. “I know I’ve laid in bed plenty of nights in the middle of treatment, wondering what it would be like and envisioning and the happiness that we both feel being at the end of this treatment.”

Libbi has been battling Wilms Tumorsince September 30, 2020. This is a rare diagnosis. So rare that, according to cancer.net, only 500-600 children in the United States receive this diagnosis each year.

Stephanie LeDuff is Libbi’s mom. “Basically, the tumor was on her right kidney. So she had to have surgery right away. They removed the tumor and the kidney. And after that, she started chemotherapy. It was all outpatient chemotherapy, a 19-week regimen. She did really well. And her prognosis was really good,” she said.

Last year, Libbi was set to ring the very same bell. But that didn’t end up happening. “Unfortunately, that day when we came in, instead of ringing a bell, we found out that her cancer had relapsed. It was very large. It was very aggressive,”  Stephanie said.

But, throughout her treatments of radiation, chemotherapy, and transfusions, Libbi persevered. “It’s amazing to see she’s now three years old. And in the midst of all of this, this treatment and chemo, she’s thriving, and she’s well, and she’s happy. And we’re just so grateful for that,” said Stephanie.

WINK News asked the family what was next. Thye said one of the first things for Libbi is to get back to school full-time. Her mother says that she will be getting a CT scan as her official end of treatment in two weeks.

Copyright ©2024 Fort Myers Broadcasting. All rights reserved.

This material may not be published, broadcast, rewritten, or redistributed without prior written consent.